Dow Up0.11% Nasdaq Up0.50%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
11.57 Up 0.12(1.05%) Aug 29, 4:00PM EDT
|After Hours : 11.60 Up 0.03 (0.26%) Aug 29, 7:56PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development12,177  12,842  10,107  11,341  
Selling General and Administrative3,589  3,393  3,388  2,734  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (15,766) (16,235) (13,495) (14,075)
Income from Continuing Operations
Total Other Income/Expenses Net117  158  153  166  
Earnings Before Interest And Taxes(15,649)(16,077)(13,342)(13,909)
Interest Expense8  11  8  10  
Income Before Tax(15,657)(16,088)(13,350)(13,919)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(15,657)(16,088)(13,350)(13,919)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (15,657) (16,088) (13,350) (13,919)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (15,657) (16,088) (13,350) (13,919)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.